These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24060850)

  • 41. [Interaction of the hepatitis C virus with the cellular membrane].
    Sanz-Cameno P; Borque MJ; García-Buey L; Moreno-Otero R
    Gastroenterol Hepatol; 2002 Oct; 25(8):521-5. PubMed ID: 12361536
    [No Abstract]   [Full Text] [Related]  

  • 42. Of mice and men: a small animal model of hepatitis C virus replication.
    Brass V; Blum HE; Moradpour D
    Hepatology; 2002 Mar; 35(3):722-4. PubMed ID: 11870390
    [No Abstract]   [Full Text] [Related]  

  • 43. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
    J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
    Hartlage AS; Walker CM; Kapoor A
    J Virol; 2020 May; 94(10):. PubMed ID: 32102885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.
    Moriya K; Yotsuyanagi H; Shintani Y; Fujie H; Ishibashi K; Matsuura Y; Miyamura T; Koike K
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1527-31. PubMed ID: 9225025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneous claudin-1 expression in human liver.
    Harris HJ; Wilson GK; Hübscher SG; McKeating JA
    Hepatology; 2013 Feb; 57(2):854-5. PubMed ID: 22807091
    [No Abstract]   [Full Text] [Related]  

  • 47. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    Douam F; Fusil F; Enguehard M; Dib L; Nadalin F; Schwaller L; Hrebikova G; Mancip J; Mailly L; Montserret R; Ding Q; Maisse C; Carlot E; Xu K; Verhoeyen E; Baumert TF; Ploss A; Carbone A; Cosset FL; Lavillette D
    PLoS Pathog; 2018 Mar; 14(3):e1006908. PubMed ID: 29505618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically humanized mice recapitulate the entire hepatitis C virus life cycle.
    Mailly L; Zeisel MB; Baumert TF
    J Hepatol; 2014 Mar; 60(3):671-3. PubMed ID: 24128418
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
    Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
    Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal Models Used in Hepatitis C Virus Research.
    Berggren KA; Suzuki S; Ploss A
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unscrambling hepatitis C virus-host interactions.
    Chisari FV
    Nature; 2005 Aug; 436(7053):930-2. PubMed ID: 16107831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis.
    Grakoui A; Hanson HL; Rice CM
    Hepatology; 2001 Mar; 33(3):489-95. PubMed ID: 11230726
    [No Abstract]   [Full Text] [Related]  

  • 53. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human serum amyloid A protein inhibits hepatitis C virus entry into cells.
    Cai Z; Cai L; Jiang J; Chang KS; van der Westhuyzen DR; Luo G
    J Virol; 2007 Jun; 81(11):6128-33. PubMed ID: 17329325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral dynamics in hepatitis C.
    Kershenobich D; Henonin CH
    Isr Med Assoc J; 2001 May; 3(5):360-3. PubMed ID: 11411202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.
    Georgel P; Schuster C; Zeisel MB; Stoll-Keller F; Berg T; Bahram S; Baumert TF
    Trends Mol Med; 2010 Jun; 16(6):277-86. PubMed ID: 20537953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bringing the Hepatitis C Virus to Life.
    Cell; 2016 Sep; 167(1):39-42. PubMed ID: 27634322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus entry: role of host and viral factors.
    Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
    Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
    Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
    Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.